Wainamics, Inc.
Campbell, CA
- UEI
- F3ALHDDT12M3
- CAGE
- 78V75
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 492 Division St, Campbell, CA 95008, USA
- Website
- wainamics.com
- Founded
- 2014
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Industrials
- Capital Goods
- Industrial Conglomerates
- Industrials & Manufacturing
- SIC code
- 38 Instruments & Related Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $375,000 |
| FY2025 | $0 |
| FY2024 | $899,527 |
| FY2023 | $149,942 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | National Aeronautics and Space Administration | $375,000 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase II - long term cell culture monitoring system | Shared Services Center | $1,274,527 | |
| Sbir phase i long term cell culture monitoring system | Shared Services Center | $149,942 |
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Astrion Group, LLC | 80ARC021D0001 | $375,135 |
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Arizona State University | R33CA309724 | $119,804 |
Similar vendors
About the company
Wainamics, Inc., doing business as Wainamics Inc., is a minority-owned, woman-owned, and economically disadvantaged small business based in Pleasanton, California. The company specializes in advanced biomedical research and development, with a focus on microfluidics and diagnostic technologies. Registered with the U.S. federal government since October 2014, Wainamics has established itself as a valuable partner for federal agencies, providing innovative solutions in cell culture monitoring systems and CRISPR-based diagnostic tools. The company's expertise spans the development of sophisticated biomedical monitoring systems and novel microfluidic cartridges, contributing to advancements in space exploration, life sciences, and cutting-edge diagnostic technologies.
Wainamics has secured significant federal contract awards through the Small Business Innovation Research (SBIR) program, primarily from the National Aeronautics and Space Administration (NASA). In August 2023, the company was awarded a Phase I SBIR contract worth $149,942 to develop a long-term cell culture monitoring system. Building on this success, Wainamics received a Phase II SBIR contract in June 2024, valued at $899,527, to further advance the long-term cell culture monitoring system. Both contracts were awarded through NASA's Shared Services Center and designated for total small business participation. These awards highlight Wainamics' capability to create sophisticated biomedical monitoring systems that align with NASA's research objectives, potentially contributing to advancements in space exploration and life sciences. The company's work under these contracts demonstrates its expertise in developing innovative technologies for long-term cell culture monitoring, which has applications in both space-based and terrestrial research environments.
In addition to its federal contracts, Wainamics has secured federal grant sub-awards through collaborations with academic institutions, particularly the University of California. These sub-awards focus on the development of novel microfluidic cartridges and diagnostic solutions using CRISPR technology. The scope of work includes optimizing cartridge designs for saliva sample processing, enhancing system performance for optical data collection, and refining on-cartridge assays for improved reproducibility and detection limits. Wainamics' responsibilities encompass a range of tasks, including cartridge optimization for repeatability, system optimization for assay steps and optical data collection, on-cartridge assay optimization for limit of detection studies, coordination of instrument engineering development efforts, and transfer of designs to injection molding for scalability. The company's work on these projects involves collaboration with the Doudna Lab and coordination with entities like Fusion Biotec for instrument development. These grant-funded projects demonstrate Wainamics' critical role in advancing cutting-edge biomedical technologies and its ability to contribute to federally funded research initiatives in partnership with prestigious academic institutions.
Quick answers
Is Wainamics, Inc. registered in SAM.gov?
Yes. Wainamics, Inc.'s SAM.gov registration is active through February 9, 2027.
How much has Wainamics, Inc. received in federal contracts?
Federal contracts obligated $1,424,469 to Wainamics, Inc. in fiscal years 2023 through 2027.
What is Wainamics, Inc.'s most recent federal award?
Wainamics, Inc.'s most recent federal contract award is Sbir phase II - long term cell culture monitoring system (80NSSC24CA160), from Shared Services Center, on June 14, 2024.
On GovTribe
See Wainamics, Inc.'s full federal record
- Federal contract awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors